SHPMF (Shanghai Pharmaceuticals Holding Co) Other Stockholders Equity: $4,564 Mil (As of Mar. 2026)


SHPMF Shanghai Pharmaceuticals Holding Co Ltd SHPMF
77 GF Score
Price $1.46
GF Value $1.81
! 4 Warning Signs
View Full Analysis

What is Shanghai Pharmaceuticals Holding Co Other Stockholders Equity?

Shanghai Pharmaceuticals Holding Co SHPMF -4.58% 77 Other Stockholders Equity is $4,564 Mil as of Mar. 2026. GuruFocus rates SHPMF with a GF Score™ of 77/100 and a GF Value™ of $1.81. The stock has 4 warning signs investors should review.

Shanghai Pharmaceuticals Holding Co's Other Stockholders Equity for the quarter that ended in Mar. 2026 was $4,564 Mil.

Shanghai Pharmaceuticals Holding Co's quarterly Other Stockholders Equity declined from Sep. 2025 ($4,418 Mil) to Dec. 2025 ($258 Mil) but then increased from Dec. 2025 ($258 Mil) to Mar. 2026 ($4,564 Mil).

Shanghai Pharmaceuticals Holding Co's annual Other Stockholders Equity increased from Dec. 2023 ($215 Mil) to Dec. 2024 ($252 Mil) and increased from Dec. 2024 ($252 Mil) to Dec. 2025 ($258 Mil).

Shanghai Pharmaceuticals Holding Co Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Shanghai Pharmaceuticals Holding Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co Other Stockholders Equity Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 344.70 222.89 214.57 251.72 257.79

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,334.50 254.43 4,417.96 257.79 4,563.64
SHPMF
77GF Score
Shanghai Pharmaceuticals Holding Co Ltd SHPMF
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Pharmaceuticals Holding Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $4,564 Mil mean?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a Other Stockholders Equity of $4,564 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors.
Is Shanghai Pharmaceuticals Holding Co's Other Stockholders Equity too high?
Shanghai Pharmaceuticals Holding Co's current Other Stockholders Equity is $4,564 Mil. Overall, Shanghai Pharmaceuticals Holding Co has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Pharmaceuticals Holding Co's Other Stockholders Equity compare to MCK and CAH?
Shanghai Pharmaceuticals Holding Co's Other Stockholders Equity of $4,564 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Distribution company?
A good Other Stockholders Equity depends on the Medical Distribution industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors. Shanghai Pharmaceuticals Holding Co's current Other Stockholders Equity is $4,564 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Pharmaceuticals Holding Co stock overvalued right now?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a current Other Stockholders Equity of $4,564 Mil. The stock's GF Value™ is $1.81, compared to a current price of $1.46 — trading 19.3% below its estimated fair value. The current Other Stockholders Equity is $4,564 Mil. Shanghai Pharmaceuticals Holding Co's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Shanghai Pharmaceuticals Holding Co (SHPMF), the current Other Stockholders Equity is $4,564 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Pharmaceuticals Holding Co (SHPMF) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued. The current stock price of $1.46 is trading 19.3% below its estimated GF Value™ of $1.81.

Key valuation signals for SHPMF:

  • Other Stockholders Equity: $4,564 Mil
  • GF Value™: $1.81 vs. price of $1.46 (19.3% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the SHPMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Pharmaceuticals Holding Co Business Description

Address No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
77GF Score

Get the complete analysis for SHPMF

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.46
Price
$1.81
GF Value